ARTICLE | Company News
Cengent, Inncardio deal
April 18, 2005 7:00 AM UTC
Metabolic company, INDO, will acquire structure-based discovery company Cengent for an undisclosed sum. Cengent has Type II diabetes compounds that inhibit PTP-1B in lead optimization. ...